IL147741A0 - Combination of active agents, said combination containing clonidine - Google Patents

Combination of active agents, said combination containing clonidine

Info

Publication number: IL147741A0
Authority: IL; Israel
Prior art keywords: combination; active agents; containing clonidine; clonidine; combination containing
Prior art date: 1999-08-19

Application number

IL14774100A

Other languages

English (en)

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-19

Filing date

2000-08-09

Publication date

2002-08-14

2000-08-09 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2002-08-14 Publication of IL147741A0 publication Critical patent/IL147741A0/xx

Links

GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 title 1
239000013543 active substance Substances 0.000 title 1
229960002896 clonidine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

IL14774100A 1999-08-19 2000-08-09 Combination of active agents, said combination containing clonidine IL147741A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19938825A DE19938825A1 (de)	1999-08-19	1999-08-19	Wirkstoffkombination mit Clonidin
PCT/EP2000/007718 WO2001013902A2 (de)	1999-08-19	2000-08-09	Wirkstoffkombination enthaltend clonidin und pramipexol

Publications (1)

Publication Number	Publication Date
IL147741A0 true IL147741A0 (en)	2002-08-14

Family

ID=7918574

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL14774100A IL147741A0 (en)	1999-08-19	2000-08-09	Combination of active agents, said combination containing clonidine

Country Status (19)

Country	Link
US (1)	US20020010201A1 (de)
EP (1)	EP1210081A2 (de)
JP (1)	JP2003507420A (de)
KR (1)	KR20020060163A (de)
AR (1)	AR025330A1 (de)
AU (1)	AU6440600A (de)
BR (1)	BR0013353A (de)
CA (1)	CA2376606A1 (de)
CO (1)	CO5200840A1 (de)
CZ (1)	CZ2002515A3 (de)
DE (1)	DE19938825A1 (de)
IL (1)	IL147741A0 (de)
MX (1)	MXPA02001138A (de)
NO (1)	NO20020793D0 (de)
PE (1)	PE20010642A1 (de)
PL (1)	PL353358A1 (de)
TR (1)	TR200200449T2 (de)
UY (1)	UY26293A1 (de)
WO (1)	WO2001013902A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10041478A1 (de)	2000-08-24	2002-03-14	Sanol Arznei Schwarz Gmbh	Neue pharmazeutische Zusammensetzung
MXPA04005572A (es)	2001-12-11	2004-12-06	Univ Virginia	Uso de pramipexol para tratamiento de esclerosis lateral amiotrofica.
US20040048779A1 (en) *	2002-05-06	2004-03-11	Erwin Schollmayer	Use of rotigotine for treating the restless leg syndrome
DE10220230A1 (de) *	2002-05-06	2003-11-27	Sanol Arznei Schwarz Gmbh	Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
DE60322067D1 (de)	2002-08-30	2008-08-21	Kyowa Hakko Kogyo Kk	Adenosin-a2a-rezeptorantagonisten zur behandlung des syndroms der unruhigen beine oder nächtlichen myoklonus
DE60204229T2 (de) *	2002-12-02	2006-02-02	Schwarz Pharma Ag	Verabreichung von Rotigotine zur Behandlung der Parkinson'schen Krankheit durch Iontophorese
US8518926B2 (en)	2006-04-10	2013-08-27	Knopp Neurosciences, Inc.	Compositions and methods of using (R)-pramipexole
KR20090021169A (ko)	2006-05-16	2009-02-27	크놉 뉴로사이언시스 인코포레이티드	Ｒ(+) 및 ｓ(-) 프라미펙솔을 포함하는 조성물 및 이의 사용 방법
WO2008009664A2 (en) *	2006-07-19	2008-01-24	Boehringer Ingelheim International Gmbh	Treatment of pain
US8524695B2 (en)	2006-12-14	2013-09-03	Knopp Neurosciences, Inc.	Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
CN101715443A (zh)	2007-03-14	2010-05-26	诺普神经科学股份有限公司	手性纯化的取代的苯并噻唑二胺的合成
EP1987815A1 (de) *	2007-05-04	2008-11-05	Schwarz Pharma Ag	Im Mund-Nasen-Rachenraum verabreichbare pharmazeutische Zusammensetzungen enthaltend Dopaminagonisten zur Vorbeugung und/oder Behandlung von unruhigen Gliedmassen
US20110190356A1 (en)	2008-08-19	2011-08-04	Knopp Neurosciences Inc.	Compositions and Methods of Using (R)- Pramipexole
WO2013096816A1 (en)	2011-12-22	2013-06-27	Biogen Idec Ma Inc.	Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
WO2014105783A1 (en) *	2012-12-28	2014-07-03	Noven Pharmaceuticals, Inc.	Compositions and methods for transdermal delivery of amphetamine and clonidine
US9662313B2 (en)	2013-02-28	2017-05-30	Knopp Biosciences Llc	Compositions and methods for treating amyotrophic lateral sclerosis in responders
ES3043076T3 (en)	2013-07-12	2025-11-24	Areteia Therapeutics Inc	Treating elevated levels of eosinophils and/or basophils
US9468630B2 (en)	2013-07-12	2016-10-18	Knopp Biosciences Llc	Compositions and methods for treating conditions related to increased eosinophils
ES2871556T3 (es)	2013-08-13	2021-10-29	Knopp Biosciences Llc	Composiciones y métodos para el tratamiento de la urticaria crónica
WO2015023786A1 (en)	2013-08-13	2015-02-19	Knopp Biosciences Llc	Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3937271A1 (de) *	1989-11-09	1991-05-16	Boehringer Ingelheim Kg	Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
DE4325491A1 (de) *	1993-07-29	1995-02-02	Boehringer Ingelheim Kg	Verwendung von zentral wirksamen alpha-2-Agonisten zur Hemmung des Postaggressionsstoffwechsels
DE19701619B4 (de) *	1997-01-17	2007-10-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verwendung von Pramipexol zur Behandlung des restless legs syndroms
US6001861A (en) *	1998-01-16	1999-12-14	Pharmacia & Upjohn Company	Use of pramipexole in the treatment of restless legs syndrome
WO2000054773A1 (en) *	1999-03-12	2000-09-21	Nitromed, Inc.	Dopamine agonists in combination with nitric oxide donors, compositions and methods of use

1999
- 1999-08-19 DE DE19938825A patent/DE19938825A1/de not_active Withdrawn
2000
- 2000-08-09 CZ CZ2002515A patent/CZ2002515A3/cs unknown
- 2000-08-09 MX MXPA02001138A patent/MXPA02001138A/es unknown
- 2000-08-09 BR BR0013353-1A patent/BR0013353A/pt not_active Application Discontinuation
- 2000-08-09 KR KR1020027002149A patent/KR20020060163A/ko not_active Withdrawn
- 2000-08-09 CA CA002376606A patent/CA2376606A1/en not_active Abandoned
- 2000-08-09 JP JP2001518040A patent/JP2003507420A/ja active Pending
- 2000-08-09 AU AU64406/00A patent/AU6440600A/en not_active Abandoned
- 2000-08-09 EP EP00951485A patent/EP1210081A2/de not_active Withdrawn
- 2000-08-09 WO PCT/EP2000/007718 patent/WO2001013902A2/de not_active Ceased
- 2000-08-09 IL IL14774100A patent/IL147741A0/xx unknown
- 2000-08-09 PL PL00353358A patent/PL353358A1/xx not_active Application Discontinuation
- 2000-08-09 TR TR2002/00449T patent/TR200200449T2/xx unknown
- 2000-08-15 UY UY26293A patent/UY26293A1/es not_active Application Discontinuation
- 2000-08-17 PE PE2000000836A patent/PE20010642A1/es not_active Application Discontinuation
- 2000-08-18 AR ARP000104292A patent/AR025330A1/es unknown
- 2000-08-18 CO CO00062317A patent/CO5200840A1/es not_active Application Discontinuation
2001
- 2001-10-04 US US09/970,839 patent/US20020010201A1/en not_active Abandoned
2002
- 2002-02-18 NO NO20020793A patent/NO20020793D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP2003507420A (ja)	2003-02-25
EP1210081A2 (de)	2002-06-05
AR025330A1 (es)	2002-11-20
TR200200449T2 (tr)	2002-08-21
CO5200840A1 (es)	2002-09-27
CZ2002515A3 (cs)	2002-05-15
PL353358A1 (en)	2003-11-17
NO20020793L (no)	2002-02-18
PE20010642A1 (es)	2001-06-08
UY26293A1 (es)	2001-04-30
NO20020793D0 (no)	2002-02-18
CA2376606A1 (en)	2001-03-01
WO2001013902A2 (de)	2001-03-01
WO2001013902A3 (de)	2001-08-23
DE19938825A1 (de)	2001-04-26
BR0013353A (pt)	2002-04-23
AU6440600A (en)	2001-03-19
US20020010201A1 (en)	2002-01-24
MXPA02001138A (es)	2002-10-31
KR20020060163A (ko)	2002-07-16

Publication	Publication Date	Title
EG24411A (en)	2009-05-25	Pharmaceutically active compounds
GB9924020D0 (en)	1999-12-15	Pharmaceutically active compounds
IL149554A0 (en)	2002-11-10	Fungicidal combinations of active substances
HUP0104131A3 (en)	2003-05-28	Amine reaction compounds comprising one or more active ingredient
GB9823101D0 (en)	1998-12-16	Pharmaceutically active compounds
AU6440600A (en)	2001-03-19	Combination of active agents, said combination containing clonidine
IL146117A0 (en)	2002-07-25	New pharmaceutically active compounds
PL352468A1 (en)	2003-08-25	Atherapeutic agent containing botuline neurotoxin
IL142807A0 (en)	2002-03-10	Controlled delivery of active agents
ZA200108000B (en)	2002-11-27	Cosmetic compounds.
GB9823102D0 (en)	1998-12-16	Pharmaceutically active compounds
IL152514A0 (en)	2003-05-29	Fungicidal combinations of active agents
AU3078000A (en)	2000-08-07	Heterocyclic compounds and antitumor agents containing the same as the active ingredient
PL349393A1 (en)	2002-07-15	Sulphonyloxazolamines as therapeutic active ingredients
AU1969800A (en)	2000-07-03	Combination of active agents
PL349862A1 (en)	2002-09-23	Fungicidal active substance combinations
HUP0201201A3 (en)	2003-03-28	Endoparasiticidal agents
ZA200110046B (en)	2003-03-06	Therapeutic agents.
ZA200109120B (en)	2003-11-13	Use of Arylalkanoylpyridazines.
HUP0201986A3 (en)	2005-01-28	Fungicidal combinations of active substances
GB9827901D0 (en)	1999-02-10	Active semiconductor
GB9926630D0 (en)	2000-01-12	Pharmacologically active compounds
IL135168A0 (en)	2001-05-20	Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors
AU2162900A (en)	2000-06-19	Microparticles containing water insoluble active agents
ZA97457B (en)	1997-10-29	Microemulsions for use as vehicles for administration of active compounds.